These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23019256)

  • 1. Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates.
    Chan PC; Yang CH; Chang LY; Wang KF; Kuo YC; Lin CJ; Lee SW; Hsueh PR; Fang CT; Huang LM
    Thorax; 2013 Mar; 68(3):263-8. PubMed ID: 23019256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan.
    Huang YW; Shen GH; Lee JJ; Yang WT
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1430-5. PubMed ID: 20937183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.
    Wolf T; Goetsch U; Oremek G; Bickel M; Khaykin P; Haberl A; Bellinger O; Gottschalk R; Brodt HR; Stephan C
    J Infect; 2013 Apr; 66(4):376-80. PubMed ID: 23159357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
    del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Mycobacterium tuberculosis infection among healthcare workers in New Zealand: prospective comparison between the tuberculin skin test and the QuantiFERON-TB Gold In-Tube assay.
    Freeman JT; Marshall RJ; Newton S; Austin P; Taylor S; Chew TC; Gavaghan S; Roberts SA
    N Z Med J; 2012 Feb; 125(1349):21-9. PubMed ID: 22327155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative performance of tuberculin skin test and QuantiFERON TB-gold in contact investigations for tuberculosis].
    Komukai J; Matsumoto K; Tomihara A; Miyake Y; Tatsumi T; Arima K; Danno K; Hirota S; Yoshida H; Koda S; Terakawa K; Shimouchi A
    Kekkaku; 2011 Nov; 86(11):847-56. PubMed ID: 22250463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.
    Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G
    New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.
    Dagnew AF; Hussein J; Abebe M; Zewdie M; Mihret A; Bedru A; Chanyalew M; Yamuah L; Medhin G; Bang P; Doherty TM; Hailu A; Aseffa A
    BMC Res Notes; 2012 Aug; 5():415. PubMed ID: 22870897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the performance of QuantiFERON-TB Gold and Mantoux test in detecting latent tuberculosis infection among Iranian health care workers.
    Talebi-Taher M; Javad-Moosavi SA; Entezari AH; Shekarabi M; Parhizkar B
    Int J Occup Med Environ Health; 2011 Dec; 24(4):359-66. PubMed ID: 22086450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests.
    Demkow U; Broniarek-Samson B; Filewska M; Lewandowska K; Maciejewski J; Zycinska K; Zwolska Z; Kus J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():209-17. PubMed ID: 19218645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients.
    Sayarlioğlu H; Gül M; Eren Dağli C; Doğan E; Sahin M; Uçar MA; Köksal N; Sayarlioğlu M; Tahta MK
    Tuberk Toraks; 2011; 59(2):105-10. PubMed ID: 21740383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.